These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 1830099)
21. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I; Johansson C; Ogren SO Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333 [TBL] [Abstract][Full Text] [Related]
22. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses. Dedeoğlu A; Fisher LA J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928 [TBL] [Abstract][Full Text] [Related]
24. The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Nomikos GG; Arborelius L; Svensson TH Eur J Pharmacol; 1992 Jun; 216(3):373-8. PubMed ID: 1425929 [TBL] [Abstract][Full Text] [Related]
25. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832 [TBL] [Abstract][Full Text] [Related]
27. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Tricklebank MD; Forler C; Fozard JR Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568 [TBL] [Abstract][Full Text] [Related]
28. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Yamada J; Sugimoto Y; Horisaka K Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671 [TBL] [Abstract][Full Text] [Related]
29. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Marsden CA; Martin KF Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656 [TBL] [Abstract][Full Text] [Related]
30. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors. Björk L; Mellin C; Hacksell U; Andén NE Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582 [TBL] [Abstract][Full Text] [Related]
31. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304 [TBL] [Abstract][Full Text] [Related]
32. Antagonism of 8-OH-DPAT-induced behaviour in rats. Berendsen HH; Broekkamp CL; Van Delft AM Eur J Pharmacol; 1990 Oct; 187(1):97-103. PubMed ID: 2148726 [TBL] [Abstract][Full Text] [Related]
33. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome. Smith LM; Peroutka SJ Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947 [TBL] [Abstract][Full Text] [Related]
35. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site. Middlemiss DN Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235 [TBL] [Abstract][Full Text] [Related]
36. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Bill DJ; Knight M; Forster EA; Fletcher A Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017 [TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. Francis PT; Pangalos MN; Pearson RC; Middlemiss DN; Stratmann GC; Bowen DM J Pharmacol Exp Ther; 1992 Jun; 261(3):1273-81. PubMed ID: 1534843 [TBL] [Abstract][Full Text] [Related]
38. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Hjorth S; Magnusson T Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):463-71. PubMed ID: 2469021 [TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-Furyl)- and R-8-phenyl-2-(di-n-propylamino) tetralin, two novel 5-HT1A receptor agonists in-vitro with different properties in-vivo. Yu H; Liu Y; Li HB; Martin AR; Hacksell U; Lewander T J Pharm Pharmacol; 1997 Feb; 49(2):169-77. PubMed ID: 9055190 [TBL] [Abstract][Full Text] [Related]
40. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists. Ahlenius S; Larsson K Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]